ida et al242 observed a
decrease in restenosis and reocclusion at 6, 12, and 24 months
in patients treated with cilostazol compared with ticlopidine,
similar to the beneÔ¨Åcial effect observed with cilostazol in
improving patency of coronary interventions and FP angioplasty in patients with end-stage renal failure.243

6. SURVEILLANCE AFTER REVASCULARIZATION
